Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India .
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF has launched AI-led infertility treatment in India, integrating two advanced systems: SiD (Sperm Identification Device) for optimising sperm selection and ERICA (Embryo Ranking Intelligent Classification Assistant) for objective embryo ranking. The technology was inaugurated by Union Minister Nitin Gadkari. The AI integration is done in partnership with IVF 2.0, a UK-based embryology innovation firm founded by renowned embryologists Dr. Jacques Cohen and Dr. Alejandro Chave. Early clinical observations suggest improved fertilisation and blastocyst development rates, potentially reducing the need for repeat IVF cycles for patients. This development comes just one month after Gaudium IVF became India's first publicly listed IVF chain.
This is a technology and product innovation announcement that positions Gaudium IVF as an industry pioneer in AI-assisted fertility treatment. While it highlights competitive differentiation and potential clinical benefits, no direct financial impact or order values were disclosed in this filing.